Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
mifepristone
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Double-Blind Trial of Mifepristone vs Placebo for Unresectable Meningioma (Summary Last Modified 10/1999)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-9005
, E-S9005
2.
Phase II Study of Mifepristone (RU486) in Women with Hormone-Responsive Metastatic Breast Cancer (Summary Last Modified 09/94)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
Protocol IDs:
LBMMC-05193
, NCI-V94-0462
3.
Phase II Study of Mifepristone in Persistent or Recurrent Epithelial Ovarian Carcinoma (Summary Last Modified 07/97)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Other
Protocol IDs:
CH-RP-9368
, NCI-V95-0711
4.
Phase II Study of the Antiprogestational Agent RU486 in Patients with Unresectable Meningioma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
LAC-USC-6M871
, NCI-V87-0233
5.
Phase II Study of the Progesterone Antagonist Mifepristone in Postmenopausal Patients with Stage IV Breast Cancer (Summary Last Modified 01/95)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
postmenopausal
Sponsor:
Protocol IDs:
CAN-NCIC-IND73
, NCI-V92-0088, IND73
6.
Mifepristone (RU-486) in Androgen Independent Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
04-249
, NCT00140478
7.
Phase II Study of Mifepristone in Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
GOG-0170K
, GOG-0170K, NCT00459290
8.
Mifepristone for Patients With Endometrial Cancer and LGESS
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
Not specified
Sponsor:
Other
Protocol IDs:
ID01-212
, NCT00505739
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute